Streamline the transition from development to manufacturing with our tech transfer and scale-up solutions. We have everything you need to get your biologics innovations to the finish line.
Tech transfer in biologics production involves transferring the processes developed during the discovery and development stages to the manufacturing stage. We can provide a streamlined tech transfer process for your biologics innovations, helping to ensure the successful commercialization of your products.
Tech transfer and scale-up are critical for bringing new biologics to market:
Tech transfer and scale-up are complex processes that require careful planning and execution to ensure the successful commercial production of high-quality biologics.
Tech transfer can be complex and time-consuming, leading to bottlenecks in product scale-up. Our tech transfer solutions can help you to plan, prepare, implement and validate tech transfer to streamline your product scale-up. An efficient tech transfer can reduce costs, improve product quality and accelerate the commercialization of your biologics innovations.
We are a global CDMO and biosimilar developer dedicated to impacting the global healthcare landscape by bringing trusted and affordable medicines to market, quickly.
Committed to innovation, we have revolutionized biologics production with our patented and validated continuous bioprocess manufacturing platform, EnzeneX™, that enables us to significantly reduce the cost of producing complex biologics and monoclonal antibodies (mAbs).
Our fully-integrated services and productive pipeline of biosimilars, along with our tech transfer and scale-up solutions, are designed to cater to your project’s every need.
Fueled by our continuous innovation and armed with EnzeneX™, our fully-integrated CDMO solutions and our biosimilars pipeline are designed to help bring your biologics innovations to life.